Jill Durocher

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

June 30th, 2009
Staff Publication
Medical Abortion
Winikoff, Beverly, Dabash, Rasha, Akin, A., Dabash, R., Dilbaz, B., Aktun, H., Dursun, P., Kiran, S., Aksan, G., Dogan, B., Winikoff, B.

This study, conducted in four clinical sites in Ankara, Turkey, evaluated the efficacy and acceptability of two misoprostol regimens (400 mcg oral or sublingual) following mifepristone for medical abortion for gestations 56 days' LMP. The results demonstrate the feasibility of integrating medical abortion into health services in Turkey and the potential to increase choices for women.

Access the abstract.